Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4 Demethoxydaunorubicin
2. 4 Desmethoxydaunorubicin
3. 4-demethoxydaunorubicin
4. 4-desmethoxydaunorubicin
5. Hydrochloride, Idarubicin
6. Idarubicin
7. Imi 30
8. Imi-30
9. Imi30
10. Nsc 256439
11. Nsc-256439
12. Nsc256439
1. Idarubicin Hcl
2. 57852-57-0
3. Idamycin
4. Zavedos
5. Idarubicin (hydrochloride)
6. 4-demethoxydaunorubicin
7. Imi 30
8. Imi-30
9. 5vv3mdu5ie
10. Idarubicinhydrochloride
11. Cpd000466355
12. 4-demethoxydaunorubicin Hydrochloride
13. Mls001401448
14. Nsc-256439
15. Dsstox_cid_27775
16. Dsstox_rid_82550
17. Dsstox_gsid_47797
18. Smr000466355
19. Idamycin Pfs
20. Cas-57852-57-0
21. Nsc 256439
22. Ncgc00093976-03
23. Unii-5vv3mdu5ie
24. Idarubicin Hydrochloride Pfs
25. Sr-01000075934
26. Idamycin (tn)
27. Einecs 260-990-7
28. Idarubicin Hydrochlorid
29. Idarubicin Hydrochloride [usan:usp:inn]
30. Schembl4838
31. Mls000759470
32. Chembl1200976
33. Dtxsid0047797
34. Chebi:31686
35. Kuc110342c
36. Ex-a1148
37. Tox21_111236
38. Idarubicin Hydrochloride [mi]
39. Mfcd00897212
40. S1228
41. Idarubicin Hydrochloride (jp17/usp)
42. Idarubicin Hydrochloride [jan]
43. Akos025402118
44. Tox21_111236_1
45. Ac-5255
46. Ccg-100886
47. Cs-1061
48. Idarubicin Hydrochloride [usan]
49. Nc00136
50. Daunomycin, 4-demethoxy-, Hydrochloride
51. Idarubicin Hydrochloride [mart.]
52. Idarubicin Hydrochloride [vandf]
53. Idarubicin Hydrochloride [usp-rs]
54. Idarubicin Hydrochloride [who-dd]
55. Ncgc00093976-08
56. (1s,3s)-3-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranoside, Hydrochloride
57. As-75944
58. Hy-17381
59. Ksc-230-185-1
60. Idarubicin Hydrochloride [orange Book]
61. D01747
62. Idarubicin Hydrochloride [usp Monograph]
63. 852i570
64. Q-101407
65. Sr-01000075934-5
66. 4-demethoxydaunorubicin (nsc256439, 4-dmdr) Hcl
67. Q27262943
68. (7s,9s)-9-acetyl-7-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride
69. (7s,9s)-9-acetyl-7-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dionehydrochloride
70. (7s,9s)-9-acetyl-7-((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride
71. (7s-cis)-9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacene-5,12-dione Hydrochloride
72. 1s,3s)-3-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-.alpha.-l-lyxo-hexopyranoside, Hydrochloride
73. 5,12-naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-.alpha.-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxyhydrochloride, (7s-cis)-
74. 5,12-naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxyhydrochloride, (7s-cis)-
Molecular Weight | 534.0 g/mol |
---|---|
Molecular Formula | C26H28ClNO9 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 3 |
Exact Mass | 533.1452592 g/mol |
Monoisotopic Mass | 533.1452592 g/mol |
Topological Polar Surface Area | 177 Ų |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 912 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Idarubicin hydrochloride |
Drug Label | IDAMYCIN PFS Injection contains idarubicin hydrochloride and is a sterile, semi-synthetic, preservative-free solution (PFS) antineoplastic anthracycline for intravenous use. Chemically, idarubicin hydrochloride is 5, 12- Naphthacenedione, 9-acetyl-7-... |
Active Ingredient | Idarubicin hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml |
Market Status | Prescription |
Company | Sandoz; Fresenius Kabi Usa; Onco Therapies; Eurohlth Intl |
2 of 2 | |
---|---|
Drug Name | Idarubicin hydrochloride |
Drug Label | IDAMYCIN PFS Injection contains idarubicin hydrochloride and is a sterile, semi-synthetic, preservative-free solution (PFS) antineoplastic anthracycline for intravenous use. Chemically, idarubicin hydrochloride is 5, 12- Naphthacenedione, 9-acetyl-7-... |
Active Ingredient | Idarubicin hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml |
Market Status | Prescription |
Company | Sandoz; Fresenius Kabi Usa; Onco Therapies; Eurohlth Intl |
Topoisomerase II Inhibitors
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)
Antibiotics, Antineoplastic
Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?